Miki Takayuki | Second Department of Internal Medicine, Sapporo Medical University
スポンサーリンク
概要
関連著者
-
Miki Takayuki
Second Department of Internal Medicine, Sapporo Medical University
-
Miki Takayuki
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Miura Tetsuji
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
MIURA Tetsuji
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Miura Tetsuji
Second Department Of Internal Medicine Department Of Clinical Laboratory Medicine Sapporo Medical Un
-
Shimamoto Kazuaki
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Shimamoto Kazuaki
Second Department Of Internal Medicine (cardiovascular Medicine) Sapporo Medical University School O
-
Yano Toshiyuki
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Yano Toshiyuki
Second Department of Internal medicine, Sapporo Medical University
-
Miki Takayuki
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Shimamoto Kazuaki
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Miura Tetsuji
Second Department Of Internal Medicine Sapporo Medical University
-
Miura Tetsuji
The Second Department Of Internal Medicine Sapporo Medical College
-
Miura Tetsuji
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Shimamoto Kazuaki
Second Department Of Internal Medicine Sapporo Medical University
-
Tanno Masaya
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Tanno Masaya
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Sakamoto Jun
Second Department of Internal Medicine, Sapporo Medical University
-
Sakamoto Jun
Second Department Of Internal Medicine Sapporo Medical University
-
坂本 淳
札幌医科大学第二内科
-
Sakamoto Jun
Department Of Pharmacology School Of Medicine Sapporo Medical University
-
Ikeda Yoshihiro
Second Department Of Internal Medicine Sapporo Medical University
-
Naitoh Kazuyuki
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Naitoh Kazuyuki
Second Department of Internal medicine, Sapporo Medical University
-
Nishihara Masahiro
Second Department of Internal Medicine, Sapporo Medical University
-
Nishihara Masahiro
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Ohhori Katsuhiko
Second Department Of Internal Medicine Sapporo Medical University
-
Ohhori Katsuhiko
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Kobayashi Hironori
Second Department of Internal Medicine, Sapporo Medical University
-
Nakamura Yuichi
Second Depertment of Internal Medicine, Sapporo Medical University School of Medicine
-
Nakamura Yuichi
Second Department Of Internal Medicine Sapporo Medical University
-
Tanno Masaya
Department of phamacology, Sapporo medical University School of medicine
-
Kobayashi Hironori
Second Department Of Internal Medicine Sapporo Medical University
-
Satoh Takahiro
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Ichikawa Yoshihiko
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Terashima Yoshiaki
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Terashima Yoshiaki
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Ishikawa Satoko
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Hotta Hiroyuki
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Hotta Hiroyuki
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Takahashi Akari
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Horio Yoshiyuki
Department of Pharmacology, Sapporo Medical University
-
Sakamoto Jun
Department of Pharmacology, Sapporo Medical University School of Medicine
-
Takahashi Akari
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Horio Yoshiyuki
Department Of Pharmacology Sapporo Medical University School Of Medicine
-
Horio Yoshiyuki
Department Of Pharmacology Ii Faculty Of Medicine Osaka University
-
Horio Yoshiyuki
Department Of Pharmacology Sapporo Medical University
-
Sakamoto Jun
Department Of Chemistry Nara University Of Education
-
Nakano Atsushi
Second Department of Internal Medicine, Sapporo Medical University
-
Matuda Eiji
Fuji Gotenba Research Labs, Chugai Pharmaceutical Co., Ltd.
-
Saito Keiji
Fuji Gotenba Research Labs, Chugai Pharmaceutical Co., Ltd.
-
Matuda Eiji
Fuji Gotenba Research Labs Chugai Pharmaceutical Co. Ltd.
-
Saito Keiji
Fuji Gotenba Research Labs Chugai Pharmaceutical Co. Ltd.
-
Nakano Atsushi
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Kuno Atsushi
Department Of Pharmacology Sapporo Medical University School Of Medicine
-
Matsuda Eiji
Product Research Department, Chugai Pharmaceutical Co.
-
Ito Takahito
Second department of internal medicine, Sapporo medical university school of medicine
-
Hongo Tamaki
Second department of internal medicine, Sapporo medical university school of medicine
-
Ito Takahito
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Hongo Tamaki
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Ishida Hideyuki
Department of Medicine, National Defense Medical College
-
Kuno Atsushi
Department Of Obstetrics And Gynecology Suzuki Hospital
-
Tsuchida Akihito
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Liu Yongge
Rockville, Maryland
-
Miura Testuji
Second Department of Internal Medicine, Sapporo Medical University
-
Tanno Masaya
Depertment of Pharmacology, Sapporo Medical University School of Medicine
-
naitou kazuyuki
Second Department of Internal Medicine, Sapporo Medical University
-
Hishihara Masahiro
Second Department of Internal Medicine, Sapporo Medical University
-
Saitoh Keiji
Product Research Department, Chugai Pharmaceutical Co.
-
Ohnuma Yoshito
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Kuno Atsushi
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Genda Satoshi
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Matsumoto Tomoaki
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Liu Yongge
Rockville Maryland
-
Kuno Atsushi
Department Of 2nd Internal Medicine Sapporo Medical University School Of Medicine
-
Yano Toshiyuki
Department of Pharmacology, Sapporo Medical University School of Medicine
-
Takada Akifumi
Second department of medicine, Sapporo medical university school of medicine
-
Simamoto Kazuaki
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Ohori Katsuhiko
Second Department of Internal Medicine, Sapporo medical University School of medicine
-
Ishida Hideyuki
Department Of Physiology Tokai University School Of Medicine
-
Tsuchida Akihito
Second Department Of Internal Medicine Sapporo Medical University
-
Tsuchida Akihito
The Second Department Of Internal Medicine Sapporo Medical College
-
Nishino Yasuhiro
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Nishino Tasuhiro
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Saito Keiji
Product Research Dept. Chugai Pharmaceutical Co., Ltd.
-
Genda Satoshi
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Ohnuma Yoshito
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Yano Toshiyuki
Department Of Anesthesiology And Surgical Center Kumamoto University Hospital
-
Matsumoto Tomoaki
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Nishino Yasuhiro
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Nishino Tasuhiro
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Ishida Hideyuki
Department Of Digestive Tract And General Surgery Saitama Medical Center Saitama Medical University
-
Hishihara Masahiro
Second Department Of Internal Medicine Sapporo Medical University
-
Saito Keiji
Product Research Department Chugai Pharmaceutical Co. Ltd.
-
Ishida Hideyuki
Department of Physiology, Tokai University School of Medicine
-
Ishida Hideyuki
Department of Chemistry, Faculty of Engineering Science, Osaka University
著作論文
- IS071 Infarct Size Limitation by Sodium-hydrogen Exhange Inhibition Requires Activation of Mitochondrial ATP-senstive K Channeles
- OJ-104 Connexin-43 Contributes to Pro-survival Akt/GSK-3β signaling And Cardimyocyte Protection in a Receptor-specifit Manner(Cell death, apoptosis/necrosis(M),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Soci
- OJ-103 Role of Intra-mitochondrial GSK-3β in Bax Regulation And Antiapoptotic Resistance of Cardiomyocytes(Cell death, apoptosis/necrosis(M),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PE-268 Ischemic Preconditioning Modifies Interactions between Connexin43 and Protein Kinases during Myocardial Ischemia(Myocardial ischemia-reperfusion, basic/clinical-4 (IHD) PE45,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of
- OE-080 Role of GSK-3 β as a Crucial Determinant of Anti-infarct Tolerance of the Myocardium(Acute myocardial infarction, basic-1 (IHD) OE14,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Activation of δ-Opioid Receptor Suppresses Myocardial Ischemic Injury by ERK Activation during the Early Phase of Ischemia(Acute Myocardial Infarction, Basic 1 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Activation of the δ-opioid Receptor Induces Phosphorylation of Connexin43 at Ser368 by PKC-ε and Reduces Myocardial Infarct Size(Myocardial Ischemia-reperfusion, Basic 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Erythropoietin Reduces Myocardial Ischemic Injury, but not Reperfusion Injury, Through Activation of the Pl3k/Akt Pathway(Myocardial Ischemia-reperfusion, Basic 1 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PE-069 Suppression of Border Zone Remodeling by G-CSF/M-CSF Treatment Improves Ventricular Function after Infarction(Acute Myocardial Infarction, Basic 3 (IHD) : PE12)(Poster Session (English))
- OE-080 Shedding of TNF-a by Activation of ADAM17 Contributes to Activation of Tyrosine Kinase-Mediated Pathway in Ischemic Preconditioning(Myocardial Ischemia-Reperfusion, Basic and Clinical 1 (IHD) : OE10)(Oral Presentation (English))
- OE-079 Suppression of Gap Junction Permeability Is a Mechanism of Cardioprotection Afforded by Activation of the Mitochondrial KATP Channel(Myocardial Ischemia-Reperfusion, Basic and Clinical 1 (IHD) : OE10)(Oral Presentation (English))
- OE-003 Mechanisms of Improvement in Post-infarct Ventricular Function by M-CSF in the rat : Increased Myocyte Regeneration vs. Modulation of Infarct Repair(Acute Myocardial Infarction, Basic 1 (IHD) : OE1)(Oral Presentation (English))
- FRS-084 Ischemia/Reperfusion Up-regulates Egr-1 Expression by an NO and ERK-mediated Mechanism in the Heart.(NO and Cardiovascular System (H) : FRS10)(Featured Research Session (English))
- Metaloprotease-Disintegrin Is Involved in Tyrosine Kinase-Mediated Signaling in Ischemic Preconditioning
- DPE-012 Activation of SIRT1, a Histone/Protein Deacetylase, by Resveratrol Up-regulates MnSOD and Suppresses the Progression of Heart Failure(DPE02,Heart Failure, Basic (M),Digital Poster Session (English),The 73rd Annual Scientific Meeting of The Japanes
- Contribution of gap junction communication to myocardial necrosis during ischemia/reperfusion
- OE-036 Roles of GSK-3 β in Myocardial Protection Afforded by Activation of the Mitochondrial K_ Channel(OE06,Myocardial Ischemia-reperfusion (Basic) (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Soci
- OE-010 Distinct Roles of PKC ε and p38MAPK in Preconditioning-induced Modulation of Gap Junction Permeability during Ischemia(OE02,ACS/AMI (Basic) (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- OE-008 Homodimeric Erythropoietin (EPO) Receptor Provokes More Potent and Distinct Cytoprotective Signaling Compared with Heterodimeric EPO-common-β Subunit Receptor in the Heart(OE02,ACS/AMI (Basic) (IHD),Oral Presentation (English),The 73rd Annual Scien
- FRS-044 ROS-mediated Enhancement of ANT-cyclophilin-D Interaction Underlies Reduced Anti-infarct Tolerance and Lost Response of Cardiomyocytes to Pro-survival Signaling in Hypertrophied Hearts(FRS9,Novel Mechanisms of Myocardial Ischemia (IHD),Featured Re
- PJ-005 Impairment of Myocardial Response to Erythropoietin-Induced Protection in Hypertensive Hypertrophied Hearts(Acute myocardial infarction, basic(02)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PE-333 Resveratrol, An Activator of Longevity Protein SIRT1, Suppresses Progression of Heart Failure Through SIRT1-mediated Cardiomyocyte Protection Against Oxidant Stress(Heart failure, basic(03)(M),Poster Session(English),The 72nd Annual Scientific Meet
- PE-222 Alteration of Akt-GSK-3β Signaling by ER Stress Underlies Failure of Erythropoietin to Protect Diabetic Hearts(Myocardial ischemia/reperfusion, basic/clinical(03)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circu
- OE-309 Relationship of the Mitochondrial K_ Channel and GSK-3β in Enhancement of Myocardial Tolerance against Infarction(Myocardial ischemia/reperfusion, basic/clinical(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Jap
- PE-443 Role of Glycogen Synthase Kinase-3 β in Cardiomyocyte Protection by Erythropoietin(Heart failure, basic-5, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-072 Ischemic Preconditioning Prevents Ischemia/reperfusion-Induced Dephosphorylation of Mitochondrial Connexin-43 in a Protein Complex with Adenine Nucleotide Translocator(Myocardial ischemia/reperfusion, basic/clinical-2, The 71st Annual Scientific Me
- PE-067 Relationships between p38MAPK and PKC in Connexin43-mediated Gap Junction Modulation by Ischemic Preconditioning(Myocardial ischemia/reperfusion, basic/clinical-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OE-126 Modulation of Mitochondrial Permeability Transition Pore Complex in GSK-3β-mediated Cardiomyocyte Protection(Myocardial ischemia/reperfusion, basic/clinical-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OE-053 Cardioprotective Signaling Provoked by Erythropoietin is Impaired in Diabetic Myocardium(Acute myocardial infarction, basic-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-046 Predictors of Improvement of Exercise Capacity by Nitrates in Experimental Heart Failure(Heart failure, basic-7 (M) PJ8,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- PE-115 Activation of ERK Compensates Disrupted PI3K-Akt Signaling in EPO-induced Cardioprotection of Post-infarct Remodeled Hearts(Acute myocardial infarction, basic-3 (IHD) PE20,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of t
- OE-025 Cardioprotection by Erythropoietin is Associated with Translocation of Akt to Mitochondria and Its Interaction with the Adenine Nucleotide Translocase(Myocardial ischemia-reperfusion, basic/clinical-1 (IHD) OE5,Oral Presentation (English),The 70th
- Protection of Post-infarct Remodeled Myocardium by Erythropoietin is Induced by a PI3K/Akt-independent and Mitochondrial K_ Channel-dependent Mechanism(Myocardial Ischemia-reperfusion, Basic 2 (IHD), The 69th Annual Scientific Meeting of the Japanese
- Erythropoietin Affords Additional Infarct Size-limiting Effects to Preconditioning through Activation of PI3K-Akt-GSK3β Pathway(Acute Myocardial Infarction, Basic 2 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Mobilization of Bone Marrow Cells Improves Ventricular Function after Myocardial Infarction by Favorable Effects on Repair in the Infarct-Noninfarct Border
- Ischemic Preconditioning (PC) Induces Dp-Regulation of GLUT4 in the Myocardium : A Possible Mechanism of Late PC against Myocardial Stunning
- Ischemic Preconditioning Enhances Engraftment of Bone Marrow-Derived Stem Cells in the Reperfused Myocardium
- Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway : Role of GSK-3β in Myocardial Protection Against Ischemia/Reperfusion Injury